GSK

Showing 15 posts of 760 posts found.

under_new_management

Pharma needs ‘radical change’ says report

April 9, 2014
Medical Communications, Sales and Marketing Chris Stirling, GSK, KPMG, digital

The pharma industry needs a complete overhaul of its entire business model with a greater focus on the patient, according …

gsk_glaxo

More manufacturing misery for GSK

April 4, 2014
Manufacturing and Production, Sales and Marketing GSK, Ireland, Paxil, cork, manufacturing

GlaxoSmithKline’s manufacturing woes are getting worse after the firm was hit with a second FDA warning in as many days. …

FDA image

FDA slams GSK for manufacturing oversights

April 3, 2014
Manufacturing and Production FDA, GMP, GSK, Ireland, cork, mage, manufacturing

The FDA has warned GlaxoSmithKline that the US importation of products from the firm’s facility in Cork, Ireland could be …

gsk image

GSK China rep speaks out over ‘bribery culture’

April 2, 2014
Medical Communications, Sales and Marketing China, GSK, Shanghai, Witty, bribery, sales

A former sales representative for GlaxoSmithKline has spoken of the firm’s alleged tactics in bribing poorly paid doctors in China …

Votrient image

‘More patients want Votrient’

April 2, 2014
Research and Development, Sales and Marketing Cancer, GSK, Pfizer, Sutent, Votrient

GlaxoSmithKline is looking at patient satisfaction as a potential marketing tool for its kidney cancer drug Votrient, setting up a …

GSK image

Lung cancer vaccine dropped

April 2, 2014
Research and Development, Sales and Marketing GSK, MAGE-A3, NSCLC, Vaccine, lung cancer, magrit

GlaxoSmithKline took a hit today after its lung cancer vaccine MAGE-A3 failed to benefit patients. The London-based firm has now …

votrient image

Votrient’s extended licence application ditched

April 1, 2014
Sales and Marketing EMA, Europe, GSK, ovarian, votrient kidney cancer

GlaxoSmithKline admits it is ‘disappointed’ after abandoning its attempt to extend kidney cancer drug Votrient’s licence to take in ovarian …

gsk image

GSK invests £130m in Africa

April 1, 2014
Manufacturing and Production, Research and Development, Sales and Marketing Africa, GSK, Nigeria, kenya, rwanda, sub-saharan

GlaxoSmithKline is to invest £130 million in sub-Saharan Africa over the next five years – money which the company says …

gsk image

GSK takes possession of Indonesian consumer healthcare unit

March 31, 2014
Manufacturing and Production, Sales and Marketing GSK, Indonesia, bognor, emerging markets, insto, sarasvati

GlaxoSmithKline has acquired full ownership of its Indonesian consumer healthcare business in a transaction which also sees the company divesting …

GSK image

Europe grants Eperzan licence

March 27, 2014
Sales and Marketing Bydureon, GSK, diabetes, eperzan, lilly

The European Commission has granted marketing authorisation to GlaxoSmithKline’s new diabetes treatment Eperzan – setting the manufacturer on a collision …

Alli image

Alli bottles tampered with in US, drug recalled

March 27, 2014
Manufacturing and Production, Sales and Marketing Alli, FDA, GSK, Roche, Xenical, obesity, weight loss

GlaxoSmithKline has admitted that some bottles of its weight-loss drug Alli bought in the US have been tampered with. US …

GSK image

GSK and partners set up big data project

March 27, 2014
Medical Communications, Research and Development, Sales and Marketing Big Data, European Bioinformatics Institute, GSK, Wellcome Trust Sanger Institute, cttv

GlaxoSmithKline, the European Bioinformatics Institute and the Wellcome Trust Sanger Institute have come together to launch an open access research …

GSK image

GSK cancer vaccine fails again

March 20, 2014
Sales and Marketing Cancer, GSK, MAGE-A3 cancer immunotherapeutic, NSCLC, lung cancer, melanoma

GlaxoSmithKline’s MAGE-A3 cancer immunotherapeutic has delivered another late-stage blow to the firm but it still vows to continue trials.  The …

GSK image

GSK increases India stake

March 11, 2014
Manufacturing and Production, Sales and Marketing FDA, GSK, India, Nashik, OTC, Thane, bangalore

GlaxoSmithKline has taken a further step into the Indian pharma market by increasing its stake in its subsidiary company there, …

The Gateway to Local Adoption Series

Latest content